Plasma level of beta endorphin in seborrheic dermatitis patients
DOI:
https://doi.org/10.15584/ejcem.2023.4.3Keywords:
beta-endorphin, itch, seborrheic dermatitisAbstract
Introduction and aim. Defects in the epidermal barrier, changes in sebum secretion and its composition, Malassezia spp. overgrowth, endocrine, immune, and neurological disorders are the main pathogenesis items of seborrheic dermatitis (SD). “The opioid system of the skin” was considered a new target in the diagnosis and treatment of SD. The study aimed to determine beta-endorphin (BE) levels in adult patients with seborrheic dermatitis and correlate them with the severity of symptoms and itching.
Material and methods. 26 healthy and 62 SD people were examined. SEDASI scale were used to estimate the severity of symptoms and intensity of itching. The determination of the beta-endorphin level was carried out by the ELISA method with the test system Human BE NBP2 (78774 Novus Biologicals).
Results. BE in the SD group was higher compared to the control group (35.5 pg/mL, 22. pg/mL, p<0.001). The level of BE in seborrheic patients did not depend on age and sex but was rising with severity of symptoms. Positive correlations were found between the level of BE and the SEDASI was 0.42 (p<.001), between the level of BE and itching was 0.332 (p=0.009).
Conclusion. SD patients have an increased level of BE that positively correlates with itching and disease severity.
Downloads
References
Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29(5):481-489. doi: 10.1111/exd.14091
Hamdino M, Saudy AA, El-Shahed LH, Taha M. Identification of Malassezia species isolated from some Malassezia associated skin diseases. J Mycol Med. 2022;32(4):101301. doi: 10.1016/j.mycmed.2022.101301
Li J, Feng Y, Liu C, et al. Presence of Malassezia Hyphae Is Correlated with Pathogenesis of Seborrheic Dermatitis. Microbiol Spectr. 2022;10(1):e0116921. doi:10.1128/spectrum.01169-21
Dityen K, Soonthornchai W, Kueanjinda P, et al. Analysis of cutaneous bacterial microbiota of Thai patients with seborrheic dermatitis. Exp Dermatol. 2022;31(12):1949-1955. doi: 10.1111/exd.14674
Yoon JS, Shim J, Lim JM, Park SG. Biophysical characteristics of dandruff-affected scalp categorized on the basis of sebum levels. J Cosmet Dermatol. 2021;20(3):1002-1008. doi: 10.1111/jocd.13626
Slominski AT, Zmijewski MA, Skobowiat C, Zbytek B, Slominski RM, Steketee JD. Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol. 2012;212:v-115. doi: 10.1007/978-3-642-19683-6_1
Bigliardi PL, Dancik Y, Neumann C, Bigliardi-Qi M. Opioids and skin homeostasis, regeneration and ageing - What's the evidence? Exp Dermatol. 2016;25(8):586-591. doi: 10.1111/exd.13021
Bigliardi-Qi M, Sumanovski LT, Büchner S, Rufli T, Bigliardi PL. Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology. 2004;209(3):183-189. doi: 10.1159/000079887
Yaksh TL, Henry JL. Antinociceptive effects of intrathecally administered human beta-endorphin in the rat and cat. Can J Physiol Pharmacol. 1978;56(5):754-759. doi: 10.1139/y78-120
Xue JZ. Changes in plasma immunoreactive beta-endorphin in burn and its clinical significance. Chinese journal of plastic surgery and burns. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1991;7(4):253-6, 317.
Allouche S, Noble F, Marie N. Opioid receptor desensitization: mechanisms and its link to tolerance. Front Pharmacol. 2014;5:280. doi: 10.3389/fphar.2014.00280
Levitt ES, Williams JT. Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons. Mol Pharmacol. 2012;82(5):983-992. doi: 10.1124/mol.112.081547
Wikramanayake TC, Borda LJ, Miteva M, Paus R. Seborrheic dermatitis-Looking beyond Malassezia. Exp Dermatol. 2019;28(9):991-1001. doi: 10.1111/exd.14006
Micali G, Lacarrubba F, Dall’Oglio F. A new proposed severity score for seborrheic dermatitis of the face: SEborrheic Dermatitis Area and Severity Index (SEDASI). J Am Acad Dermatol. 2017;76(6):AB18. doi: 10.1016/j.jaad.2017.04.088
Reich A, Heisig M, Phan NQ, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92(5):497-501. doi: 10.2340/00015555-1265
Vijayaraghavan S, Vedula SK, Bourokba N, et al. Relationship between scalp histamine levels and dandruff within an Indian population: A confirmation study using LC/MS/MS method. Exp Dermatol. 2022;31(5):814-818. doi: 10.1111/exd.14539
Viodé C, Lejeune O, Turlier V, et al. Cathepsin S, a new pruritus biomarker in clinical dandruff/seborrhoeic dermatitis evaluation. Exp Dermatol. 2014;23(4):274-275. doi: 10.1111/exd.12357
Kjaer A, Larsen PJ, Knigge U, Møller M, Warberg J. Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons. Endocrinology. 1994;134(1):482-491. doi: 10.1210/endo.134.1.8275963
Babina M, Wang Z, Roy S, et al. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway. J Invest Dermatol. 2021;141(5):1286-1296.e4. doi: 10.1016/j.jid.2020.09.017
Nakasone T, Sugimoto Y, Kamei C. The interaction between histamine H1 receptor and μ- opioid receptor in scratching behavior in ICR mice. Eur J Pharmacol. 2016;777:124-128. doi: 10.1016/j.ejphar.2016.03.005
Bigliardi-Qi M, Lipp B, Sumanovski LT, Buechner SA, Bigliardi PL. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology. 2005;210(2):91-99. doi: 10.1159/000082563
Wang Z, Jiang C, Yao H, et al. Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. Brain. 2021;144(2):665-681. doi: 10.1093/brain/awaa430
Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol. 1994;131(2):260-264. doi: 10.1111/j.1365-2133.1994.tb08502.x
Georgala S, Schulpis KH, Papaconstantinou ED, Stratigos J. Raised beta-endorphin serum levels in children with atopic dermatitis and pruritus. J Dermatol Sci. 1994;8(2):125-128. doi: 10.1016/0923-1811(94)90006-x
Ruiz-Arriaga LF, Arenas R, Vega-Sánchez DC, Asz-Sigall D, Martínez-Velazco MA. Seborrheic Dermatitis: Three Novel Trichoscopic Signs and Its Correlation to Malassezia sp. Colonization. Skin Appendage Disord. 2019;5(5):288-292. doi: 10.1159/000497782
Blebea J, Mazo JE, Kihara TK, et al. Opioid growth factor modulates angiogenesis. J Vasc Surg. 2000;32(2):364-373. doi: 10.1067/mva.2000.107763b
Dobrosi N, Tóth BI, Nagy G, et al. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J. 2008;22(10):3685-3695. doi: 10.1096/fj.07-104877
Ádám D, Arany J, Tóth KF, Tóth BI, Szöllősi AG, Oláh A. Opioidergic Signaling-A Neglected, Yet Potentially Important Player in Atopic Dermatitis. Int J Mol Sci. 2022;23(8):4140. doi:10.3390/ijms23084140
Tao K, Zhu J, Wei K, et al. Cannabinoid Receptor-2 Activation in Keratinocytes Contributes to Elevated Peripheral β-Endorphin Levels in Patients With Obstructive Jaundice. Anesth Analg. 2021;133(1):251-262. doi: 10.1213/ANE.0000000000005405
Nattkemper LA, Tey HL, Valdes-Rodriguez R, et al. The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch. J Invest Dermatol. 2018;138(6):1311-1317. doi: 10.1016/j.jid.2017.12.029
Lee H, Ko MC. Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates. Sci Rep. 2015;5:11676. doi: 10.1038/srep11676
Basso L, Boué J, Mahiddine K, et al. Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice. J Neuroinflammation. 2016;13(1):132. doi: 10.1186/s12974-016-0591-x
Fournière M, Latire T, Souak D, Feuilloley MGJ, Bedoux G. Staphylococcus epidermidis and Cutibacterium acnes: Two Major Sentinels of Skin Microbiota and the Influence of Cosmetics. Microorganisms. 2020;8(11):1752. doi: 10.3390/microorganisms8111752
Boué J, Blanpied C, Brousset P, Vergnolle N, Dietrich G. Endogenous opioid-mediated analgesia is dependent on adaptive T cell response in mice. J Immunol. 2011;186(9):5078-5084. doi: 10.4049/jimmunol.1003335
Boué J, Blanpied C, Djata-Cabral M, Pelletier L, Vergnolle N, Dietrich G. Immune conditions associated with CD4+ T effector-induced opioid release and analgesia. Pain. 2012;153(2):485-493. doi: 10.1016/j.pain.2011.11.013
Morgan EL, McClurg MR, Janda JA. Suppression of human B lymphocyte activation by beta-endorphin. J Neuroimmunol. 1990;28(3):209-217. doi: 10.1016/0165-5728(90)90014-e
Börner C, Warnick B, Smida M, et al. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling. J Immunol. 2009;183(2):882-889. doi: 10.4049/jimmunol.0802763
Börner C, Lanciotti S, Koch T, Höllt V, Kraus J. μ opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes. J Neuroimmunol. 2013;263(1-2):35-42. doi: 10.1016/j.jneuroim.2013.07.012
Hemmick LM, Bidlack JM. Beta-endorphin stimulates rat T lymphocyte proliferation. J Neuroimmunol. 1990;29(1-3):239-248. doi: 10.1016/0165-5728(90)90167-l
Stanojević S, Mitić K, Vujić V, Kovacević-Jovanović V, Dimitrijević M. Beta-endorphin differentially affects inflammation in two inbred rat strains. Eur J Pharmacol. 2006;549(1-3):157-165. doi: 10.1016/j.ejphar.2006.08.012
Labuz D, Schreiter A, Schmidt Y, Brack A, Machelska H. T lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav Immun. 2010;24(7):1045-1053. doi: 10.1016/j.bbi.2010.04.001
Mathews PM, Froelich CJ, Sibbitt WL Jr, Bankhurst AD. Enhancement of natural cytotoxicity by beta-endorphin. J Immunol. 1983;130(4):1658-1662.
Făgărăsan MO, Axelrod J, Catt KJ. Interleukin 1 potentiates agonist-induced secretion of beta-endorphin in anterior pituitary cells. Biochem Biophys Res Commun. 1990;173(3):988-993. doi: 10.1016/s0006-291x(05)80883-6
Lee CH, Hong CH, Yu WT, et al. Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis. Br J Dermatol. 2012;167(4):794-803. doi: 10.1111/j.1365-2133.2012.11047.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
